openPR Logo
Press release

Non-Steroidal Anti-Inflammatory Drugs Market Trends and Forecast to 2033 | USD 31.29 Billion Projection

05-22-2025 10:05 AM CET | Health & Medicine

Press release from: orion market research

Non-steroidal anti-inflammatory drugs Market

Non-steroidal anti-inflammatory drugs Market

The global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market was valued at approximately USD 22.58 billion in 2024 and is projected to reach between USD 31.29 billion and USD 37.6 billion by 2033, depending on varying growth forecasts. The market is anticipated to expand at a compound annual growth rate (CAGR) ranging from 5.66% to 5.8% during the period from 2025 to 2033.

Request a sample copy of this report at: https://www.omrglobal.com/request-sample/non-steroidal-anti-inflammatory-drugs-market

Non-steroidal anti-inflammatory drugs Market Overview:
The Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market plays a crucial role in the global pharmaceutical industry by providing effective treatment for pain, inflammation, and fever. These drugs are widely used to manage chronic conditions such as arthritis, cardiovascular diseases, and other inflammatory disorders. The market is driven by the rising prevalence of these health issues, an aging population, and increased awareness about pain management. Advances in drug formulations, including topical and slow-release versions, have expanded the product offerings and improved patient compliance. Additionally, the availability of over-the-counter NSAIDs has boosted market accessibility and consumer convenience. However, concerns over side effects and regulatory scrutiny continue to challenge market growth. Overall, the NSAIDs market is expected to grow steadily, fueled by continuous innovation and increasing healthcare needs worldwide.

Non-steroidal anti-inflammatory drugs Market Growth Factors:
The growth of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is primarily driven by the increasing prevalence of chronic inflammatory diseases such as arthritis, osteoarthritis, and rheumatoid arthritis worldwide. An aging global population is contributing significantly to the rising demand for effective pain relief and inflammation management. Additionally, the growing awareness of NSAIDs as a first-line treatment option for pain and fever has expanded their use across various patient groups. Innovations in drug delivery systems, including topical gels and extended-release formulations, have improved patient compliance and broadened market reach. The rising availability of over-the-counter NSAIDs also boosts consumer access and convenience. Furthermore, expanding healthcare infrastructure in developing regions is enhancing market penetration. However, ongoing research to minimize side effects and improve drug safety continues to support sustained market growth.

◘ The report further explores the Non-steroidal anti-inflammatory drugs business players along with their in-depth profiling
Pfizer Inc., GlaxoSmithKline (GSK), Bayer AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Novartis AG, AbbVie Inc., Johnson & Johnson, Sanofi S.A.

Non-steroidal anti-inflammatory drugs Market Segments:
◘ By Type: Ibuprofen, Naproxen, Aspirin, COX-2 Inhibitors
◘ By Application: Pain Relief, Anti-inflammatory, Arthritis, Headaches

Non-steroidal anti-inflammatory drugs Market Drivers & Trends Analysis:
The Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is driven by several key factors and emerging trends. The increasing incidence of chronic diseases like arthritis and other inflammatory conditions fuels steady demand for NSAIDs worldwide. Growing geriatric populations, who are more prone to such ailments, further boost market growth. There is a clear trend toward the development of safer, targeted NSAIDs with fewer side effects, enhancing patient adherence. The rise in over-the-counter (OTC) availability allows easier consumer access, expanding the market footprint. Additionally, innovations in drug delivery methods, such as topical and sustained-release formulations, improve treatment effectiveness and convenience. The adoption of digital health technologies to monitor and manage pain is also shaping market dynamics. Overall, these drivers and trends collectively contribute to the sustained expansion of the NSAIDs market.

If you have any special requirements, Request customization: https://www.omrglobal.com/report-customization/non-steroidal-anti-inflammatory-drugs-market

Regional Outlook:
The following section of the report offers valuable insights into different regions and the Non-steroidal anti-inflammatory drugs players operating within each of them. To assess the growth of a specific region or country, economic, social, environmental, technological, and political factors have been carefully considered. The section also provides readers with revenue and sales data for each region and country, gathered through comprehensive research. This information is intended to assist readers in determining the potential value of an investment in a particular region.

» North America (U.S., Canada, Mexico)
» Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
» Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
» South America (Brazil, Argentina, Rest of SA)
» Middle East & Africa (TurNon-steroidal anti-inflammatory drugs, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

Non-steroidal anti-inflammatory drugs Benefits for Stakeholders:
⏩ The study represents a quantitative analysis of the present Non-steroidal anti-inflammatory drugs Market trends, estimations, and dynamics of the market size from 2025 to 2032 to determine the most promising opportunities.
⏩ Porter's five forces study emphasizes the importance of buyers and suppliers in assisting stakeholders to make profitable business decisions and expand their supplier-buyer network.
⏩ In-depth analysis, as well as the market size and segmentation, help you identify current Non-steroidal anti-inflammatory drugs Market opportunities.
⏩ The largest countries in each region are mapped according to their revenue contribution to the market.
⏩ The Non-steroidal anti-inflammatory drugs Market research report gives a thorough analysis of the current status of the Non-steroidal anti-inflammatory drugs Market's major players.

Non-steroidal anti-inflammatory drugs questions answered in the report:
➧ What will the market development pace of the Non-steroidal anti-inflammatory drugs Market?
➧ What are the Non-steroidal anti-inflammatory drugs factors driving the Non-steroidal anti-inflammatory drugs Market?
➧ Who are the Non-steroidal anti-inflammatory drugs manufacturers in the market space?
➧ What are the market openings, market hazards,s and market outline of the Non-steroidal anti-inflammatory drugs Market?
➧ What are the sales, revenue, and price analysis of the top manufacturers of the Non-steroidal anti-inflammatory drugs Market?
➧ Who are the distributors, traders, and dealers of Non-steroidal anti-inflammatory drugs Market?
➧ What are the market opportunities and threats faced by the vendors in the Non-steroidal anti-inflammatory drugs Market?
➧ What are deals, income, and value examination by types and utilizations of the Non-steroidal anti-inflammatory drugs Market?
➧ What are deals, income, and value examination by areas of enterprises in the Non-steroidal anti-inflammatory drugs Market?

Purchase Now Up to 25% Discount on This Premium Report: https://www.omrglobal.com/buy-now/non-steroidal-anti-inflammatory-drugs-market?license_type=license-single-user

Reasons To Buy The Non-steroidal anti-inflammatory drugs Market Report:
➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging Non-steroidal anti-inflammatory drugs segments and regions
➼ Non-steroidal anti-inflammatory drugs business strategies by major market players and their Non-steroidal anti-inflammatory drugs methods

Contact Us:
Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Website: www.omrglobal.com
Follow Us: LinkedIn | Twitter

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Steroidal Anti-Inflammatory Drugs Market Trends and Forecast to 2033 | USD 31.29 Billion Projection here

News-ID: 4030347 • Views:

More Releases from orion market research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for NSAIDs

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Projected to Show Strong G …
Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Report from MR Forecast highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, player's market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions
Global Pet NSAIDs Market Research Report 2023-2029
Global Pet NSAIDs Market: Driven factors and Restrictions factors The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the future. The information presented is based on historical milestones and current trends,
Global NSAIDs Market - Opportunities & Forecasts, 2020-2029
The research report from Dhirtek Business Research and Consulting is a thorough examination of the global nsaids market. Subject matter experts and a team of highly trained researchers have worked tirelessly to compile an original research report on the global nsaids market. Analysts have researched the various items on the market and provided unbiased opinions on the variables that are expected to drive and constrain the market. To conduct a
Global Veterinary NSAIDs Market - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market is projected to grow at a CAGR value of 7.5% from 2022 and 2027. The growing demand for veterinary services, increased focus on companion animal health, growing pet adoptions, and stringent regulations on pet ownership have increased the demand for non-steroidal anti-inflammatory drugs. Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Elanco
EMEA (Europe, Middle East and Africa) NSAIDs Market Report 2017
MarketResearchReports.Biz presents this most up-to-date research on "EMEA (Europe, Middle East and Africa) NSAIDs Market Report 2017" Description In this report, the EMEA NSAIDs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue
Global NSAIDs Sales Market Report 2017
This report studies sales (consumption) of NSAIDs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Bayer (DE) Novacap (FR) Abbott Pfizer Inc Geri-Care Pharmaceuticals Perrigo Company Kopran Ltd. Merck Sharp & Dohme Corp. Sun Pharmaceutical Industries Ltd GlaxoSmithKline Reddy Pharmaceuticals Ltd Johnson & Johnson Request for Sample of Premium Research Report @ http://www.qyresearchreports.com/sample/sample.php?rep_id=962754&type=E Market Segment by Regions, this report splits